FDA Amends Final Monograph for Over-the-Counter Nasal Decongestant Drug Products

Summary

The Food and Drug Administration (FDA) is updating the final monograph for over-the-counter nasal decongestant drug products to remove a specific indication and restrict the use of certain terms on labeling, as part of its ongoing review of over-the-counter (OTC) drug products.